Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development.

Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development. Abstract Text:

    s p mcdermottS P McDermott,e a ranheimE A Ranheim,v s leatherberryV S Leatherberry,s s khwajaS S Khwaja,k s klosK S Klos,c m alexanderC M Alexander,

    We previously showed that mice with a null mutation in syndecan-1 (Sdc1; CD138) were resistant to Wnt1-induced mammary tumor initiation. The absence of Sdc1 inhibited the increase in the mammary stem cell fraction that is characteristic of preneoplasia in this model. As the tumor precursor cells are recruited from the stem/progenitor cell compartment, tumor development was also inhibited (Liu et al., 2004; PNAS 101, 4158). Although Sdc1-/- mice are grossly normal, they are systemically smaller, suggesting that developmental abnormalities may extend further than their mammary glands. We have therefore evaluated the multi-organ response of Sdc1-/- mice to carcinogen-induced tumor development (7,12-dimethylbenz[a]anthracene, DMBA), and find these mice to be resistant to tumorigenesis in all the predominant carcinogen-susceptible lineages. Thus, Sdc1-/- mice administered DMBA during juvenile development are resistant not only to epithelial tumors, including liver (60-80%) and lung tumors (C57BL6 mice, 60-80%), but also to lymphoma (over 70%, depending upon strain and carcinogen dose). We demonstrate that CD138 is expressed (heterogeneously) in the hematopoietic stem cell fraction (and not only in pre-B and plasma cells), and that tumors arise in both myeloid and lymphoid lineages. Furthermore, carcinogen-induced mammary tumors are bilineal, implying a bipotent precursor cell. Both observations imply that the DMBA-induced tumor precursor cells are drawn from the stem/progenitor fraction, and we suggest that pathogenic activation of these cells could be abnormal in Sdc1-/- mice.

    Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development. Publishing Authors By Initials

    sp mcdermottSP McDermott,ea ranheimEA Ranheim,vs leatherberryVS Leatherberry,ss khwajaSS Khwaja,ks klosKS Klos,cm alexanderCM Alexander,

    For similar membrane glycoproteins: syndecans: syndecan-1 research abstracts see: membrane glycoproteins: syndecans: syndecan-1 research

    PUBMED ID PMID:

    MEDLINE DATE:

    Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Oncogene

    VOLUME: 26

    Page Numbers: 1407-16

    Journal Abbreviation: Oncogene

    ISSN: 0950-9232

    DAY: 4

    MONTH: 09

    YEAR: 2006

    Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8711562

    Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development. Keywords Mesh Terms:

    KEYWORDS: Syndecan-1

    MESH TERMS: physiology

    Chemical & Substance for Abstract: Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development. Information

    Substance Name: 9,10-Dimethyl-1,2-benzanthracene

    Registry Number: 57-97-6

    Grant and Affiliation Information for Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development.

    AFFILIATION: McArdle Laboratory for Cancer Research, University of Wisconsin-Madison Medical School, Madison, WI 53706, USA.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NCI

    GRANT: T32 CA09135

    ACRONYM: CA

    MEDLINETA: Oncogene

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News